Am J Obstet Gynecol by DONG, Yafeng et al.
CHRONIC FETAL HYPOXIA PRODUCES SELECTIVE BRAIN
INJURY ASSOCIATED WITH ALTERED NITRIC OXIDE
SYNTHASES
Yafeng DONG, Ph.D1,2,+, Zhiyong YU, M.D.1,5,+, Yan SUN, M.D.1,6,+, Hui ZHOU, M.D.1,
Josh STITES, B.S.1, Katherine NEWELL, M.D.4, and Carl P. WEINER, M.D., M.B.A.1,2,3,+,**
1Department of Obstetrics and Gynecology
2Institute for Reproductive Health and Regenerative Medicine
3Department of Molecular and Integrative Physiology
4Department of Pathology University of Kansas School of Medicine, Kansas City, KS, 66160
5Department of Spine Surgery The Second Affiliated Hospital Jinan University Shenzhen,
Guangdong, China
6Department of Obstetrics and Gynecology Third Hospital, Hebei Medical University
Shijiazhuang, Hebei, China
Abstract
OBJECTIVE—The impact of chronic hypoxia on the nitric oxide synthase isoenzymes (NOSs) in
specific brain structures is unknown.
STUDY DESIGN—Time-mated pregnant guinea pigs were exposed to 10.5% O2 for 14d (HPX)
or room air (NMX); L-NIL (an iNOS inhibitor, 1mg/kg/day) was administered to HPX animals for
14d (L-NIL+HPX). Fetal brains were harvested at term. Multi-labeled immunofluorescence was
used to generate a brain injury map. Laser capture microdissection and quantitative PCR were
applied and cell injury markers, apoptosis activation, neuron loss, total NO, and the levels of
individual NOSs quantified.
RESULTS—Chronic hypoxia causes selective fetal brain injury rather than globally. Injury is
associated with differentially affected NO synthases in both neurons and glial cells, with iNOS up
regulated at all injury sites. L-NIL attenuated the injury despite continued hypoxia.
CONCLUSIONS—These studies demonstrate chronic hypoxia selectively injures the fetal brain
in part by the differential regulation of NOSs in an anatomic and cell specific manner.
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Fetal brain abnormalities (whether developmental or acquired) contribute to numerous
postnatal disorders ranging from learning disability to severe neurologic handicap1. On the
severe end, cerebral palsy (CP) complicates 1.5-6/1000 deliveries and is independently
associated with spontaneous preterm birth, maternal-perinatal infection-inflammation and
intrauterine growth restriction (IUGR), a frequent surrogate for chronic fetal hypoxia2. The
fact that other central nervous system (CNS) abnormalities are common in CP suggests CP
is a phenotype more than a specific injury. The estimated lifetime excess cost of CP and CP
associated disorders per individual exceeds $1.5 million3,4. The proportion of CP generally
attributed to acute intrapartum ischemia-reperfusion approximates 15% and reflects the
assumption that the intrapartum event was causative. Yet many affected newborns have
other antecedents of CP including prematurity, chorioamnionitis, IUGR or structural
malformation 5-7, and the combination of intrauterine asphyxia and inflammation
dramatically increases the risk of CP 8. In one of the few studies of the presumably
chronically hypoxic fetal brain, 43% of perinates who either died in utero or shortly after
birth had evidence of placental vascular problems such as funisitis and antemortem brain
injury including gliosis and neuronal necrosis 9. Such changes could not result from an
intrapartum event since there was inadequate elapsed time before death to account for the
findings. This body of information suggests acute intrapartum ischemia-reperfusion in
isolation is an uncommon cause of CP. It is also suggests inflammation (funisitis and gliosis)
is part of the human phenotype, and consistent with the clinical fact that early delivery of the
chronically hypoxic fetus does not improve neurodevelopmental outcome7.
The associations between intrauterine infection / inflammation and developmental brain
injury have been extensively studied. Interleukin (IL) -1 and IL-6 are central to the
pathogenesis of white matter injury mediated by intrauterine infection10,11. Tumor necrosis
factor (TNF)-α in the setting of intrauterine infection is associated with neonatal
intraventricular hemorrhage, periventricular leukomalacia and the subsequent development
of CP 10,12. Thus, it is reasonable to speculate that inflammation plays a role in the
pathogenesis of perinatal brain injury. We demonstrated that chronic hypoxia increases IL-6
and TNF-α in fetal blood of guinea pig, fulfilling the diagnostic criteria in humans for fetal
inflammatory response syndrome 13. This inflammatory response is highly associated with
both spontaneous preterm birth and subsequent neurodevelopmental compromise 14,15.
Chronic hypoxia also increased the expression of these cytokines in multiple fetal organs
including the brain 13. And while there is extensive evidence linking acute perinatal
ischemia 16 to proinflammatory cytokine and reactive oxygen species (ROS) generation 17,
no such association has been identified for the more common clinical condition associated
with neurodevelopmental compromise, chronic fetal hypoxia due to placental dysfunction.
Nitric oxide (NO) is involved in diverse physiological and pathological processes. A decade
ago, we documented that chronic hypoxia altered the expression of endothelial and neuronal
nitric oxide synthase (e or nNOS) in the ovine fetal cerebrum 18. Our finding that chronic
fetal hypoxia decreased eNOS but increased nNOS suggested the normal fetal response to
chronic hypoxia could be actually maladaptive since the lack of eNOS derived NO might
prolong an episode of ischemia while the increased nNOS could prove cytotoxic by
increasing the release of excitatory amino acids. Recently, Haynes et al applied
immunocytochemistry to archived human tissue and observed a significant increase in the
density of iNOS-expressing cells in the cerebral white matter of cases with periventricular
leukomalacia compared to control19. This study supports an important role for iNOS-
induced nitrosative stress in the reactive/inflammatory component of periventricular
leukomalacia (PVL). Herein, we test the hypothesis that fetal brain injury resulting from
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chronic hypoxia is selective rather than global, and that the anatomic sites of injury reflect
altered expression of one or more NOS isoform.
MATERIALS AND METHODS
Animal Model
Female Duncan-Hartley guinea pigs (term~65 d) were time-mated, and dams randomly
assigned to either room air (approximately 21% O2, NMX, n=6) or to an environmental
chamber containing 10.5% O2 for 14d (HPX, n=6) beginning day 46-49 (about 0.7
gestation). Normal guinea pig chow was provided without restriction. On day 60-64, a
hysterotomy was aseptically performed while dams respired spontaneously (ketamine
[80mg/kg] and xylazine [1mg/kg]), and the fetal brains collected into either formalin as
described below for histological study or frozen in liquid nitrogen for gene quantification.
Only the presenting pup was studied. We have shown in the past that the hypoxic dams gain
weight normally throughout gestation, labor and deliver without event, and that the pups are
reduced in size but have increased hemoglobin and hypoxia inducible factor measurements
20-23. In order to test the role of iNOS on fetal brain injury, L-N6-(1-Iminoethyl)-lysine (L-
NIL), a selective pharmacological inhibitor of iNOS known to cross the placenta was
administered to HPX animals in their drinking water (1mg/kg/d, L-NIL+HPX, n=6) for 14
days.
Fetal Brain Frozen Section Preparation
The fresh fetal whole brains from NMX (n=6), HPX animals (n=6), or L-NIL+HPX (n=6)
were removed and fixed in 4% paraformaldehyde overnight at 4°C, cryoprotected in 30%
sucrose at 4°C for 2-3 day until no longer buoyant, and then embedded in optimal cutting
temperature compound (OCT) for sectioning. Five sets of coronal mirror sections were
prepared for DAB-based immunostaining, multi labeled fluorescence immunostaining,
Terminal deoxynucleotidyl transferase dUTP Nick End Labeling (TUNEL) staining, Nissl
staining and Laser Capture Microdissection (LCM). The coronal sections were made at the
interaural level of 6.72mm to 5.40 mm (Bregma: from −2.28 mm to −3.60mm) of the fetal
brain, cut on a cryostat at 8μm thickness with each mirror section cut at 10μm intervals
before being stored at −20°C for later study. These sections did not include the cerebellum
and brainstem which will be studied in the future.
Fetal Brain Cell Injury Detection by Immunohistochemistry
The antibodies are described in Table 1 (Injury Index Mapping section).
The first set mirror slides were immunostained with specific antibodies against Activating
Transcription Factor 3 (ATF3), a marker of neuronal injury24, 25 and Glial Fibrillary Acidic
Protein (GFAP), a marker of glial activation26. The Universal Dako LSAB
immunohistochemistry staining assay (Dako North America, CA) was used for signal
detection. The fetal brain sections were incubated at room temperature in 3% hydrogen
peroxide for 5min and then rinsed with PBS. Primary antibodies (Table 1) to ATF3 (mouse,
1:50, Sigma, MO) and GFAP (mouse, 1:100, Sigma, MO) were applied overnight at 4°C,
labeled with streptavidin-biotin and developed in 3,3′-Diaminobenzidine (DAB) to produce
brown staining. Hematoxylin was used as a counterstain. Histological quantification was
performed as described subsequently.
Co-localization of NOS Isoforms with Cell Injury by Multi labeled Immunofluorescence
Histochemistry Staining
The second set of mirror slides were used for protein co-localization studies by multi label
immune-fluorescence histochemistry with the primary antibodies described in Table 1
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(ATF3 and NOSs Co-localization section). For ATF3 co-localization, β-tubulin III and
GFAP were used to label neurons and glial cells respectively. The primary antibodies for
ATF3 and GFAP, or ATF3 and β-tubulin III were applied to the slides and incubated
overnight at 4°C with gentle agitation. The sections then were washed 5× for 10min in
phosphate buffered saline (PBS), incubated in darkness with the specific secondary
antibodies and rinsed 5× for 10min in PBS before being mounted with DAPI and
coverslipped. Protein expression was identified under the appropriate specific fluorescence
wavelengths.
For the NOS co-localization studies, the injured areas were first detected using either ATF3
or GFAP, followed by nNOS or iNOS (primary antibodies and specific secondary antibodies
described in Table 1, NOSs Co-localization section). The staining procedure was the same
as described as above. The primary antibodies were omitted as a negative control.
Detection of Apoptotic Cells
The third set of mirror slides were used to identify apoptotic cells based on the presence of
DNA strand breaks using TUNEL. Frozen fetal brain sections were used for TUNEL
staining by the Fluorescent in Situ Cell Death Detection Kit (Roche, IN) per the
manufacturer’s instructions. The negative control was generated by using Label Solution
without terminal transferase. Positive control slides were generated by treating sections with
recombinant DNase I. Each stained section was examined by fluorescent microscopy and
TUNEL-positive cells in the fetal brain were quantified as previously reported 27.
Neuron Loss Identification by Nissl staining
The fourth set of mirror slides were used to quantify neuronal density using Nissl staining
with Cresyl violet 28 . Frozen slides were air dried for 1h, stained in Cresyl violet solution
(0.1% Cresyl violet) for 5min, rinsed in distilled water, differentiated in 95% ethyl alcohol
for 15min, dehydrated in 100% alcohol for 5min twice, cleared in xylene for 5min twice,
and then mounted by resinous medium for the quantification.
Histological Injury Marker Quantification and Reconstruction
Histological quantification was performed as previously described 27. We selected six (5)
animal from each group (NMX, HPX, and L-NIL+HPX. Five (5) slides were selected
randomly from each animal, and then 5 injured areas were randomly selected from each
slide. The grading of ATF3, GFAP and TUNEL staining intensity was determined in a blind
fashion employing a 1-4 scale: weak (+), positive stained cells in ≤25% of the surface area;
medium (++), positive cells in > 25% but <50% of the surface area; strong (+++), positive
cells in ≥50% but ≤ 70% of the surface; very strong (++++), positive cells in ≥70% of the
surface. For Nissl staining, the number of stained neurons was quantified using the Stereo
Investigator 8.0 system. Neuronal density was defined as the mean total number of neurons
per mm2.
The locations of the injured cells marked by ATF3, GFAP and TUNEL were reconstructed
from the immunostained/TUNEL stained mirror sections with the aid of a Zeiss microscope
and a Nikon fluorescent microscope. The counts of positively stained cells were performed
as described above, and the locations of GFAP, ATF3 and TUNEL positive cells projected
onto a schematic representation of the brain coronal section as previous published 29.
Laser Capture Microdissection (LCM)
The fifth and final set of mirror slides was used for laser capture microdissection (LCM).
The areas of injury identified by ATF3, GFAP or TUNEL labeling in the first four sets of
mirror sections were selectively excised using LCM. The position of anatomical landmarks
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(3rd ventricle, hippocampus, and cortex) was visually projected onto the sections for LCM
from hematoxylin stained images. LCM was performed using the Veritas Microdissection
Instrument on the unstained frozen section adjacent to the mirror section processed for either
immuno or TUNEL staining. The regions of the unstained section that corresponded to
boundaries of the injured brain areas were dissected under a 4× objective into CapSure
Macro caps, and the LCM samples then used for gene quantification. Laser settings varied
as needed from 50-75 mW (power), 1,500 – 3,500 ms (duration) and 200-250 mV
(intensity).
Quantitative Reverse Transcriptase Polymerase Chain Reaction (Q-rtPCR)
Injury index genes (ATF3, GFAP and Bax [a marker for apoptosis]) and the three NOS
isoforms (nNOS, iNOS and eNOS) mRNA expressions were quantified by SYBR Green I
labeled (BioRad Laboratories, Hercules, CA) quantitative real time PCR (Q-rtPCR) using
mRNA extracted from LCM samples and whole fetal brain as indicated. Total RNA was
isolated (RNeasy Mini Kit and RNase-Free DNase Set, Qiagen, Valencia, CA) and reverse-
transcribed (Sensiscript RT Kits, Qiagen, Valencia, CA). The primer sequence for each gene
target was based on prior publications 30,31,32,33. PCR parameters (iCyler iQ Real-time PCR
Detection System (BioRad Laboratories, Hercules, CA) consisted of an initial denaturation
at 95°C for 180sec, followed by 40 cycles at 95°C for 30sec, annealing at 60°C for 25sec,
extension at 72°C for 30sec, and 1 cycle at 72°C for 7min. A melt analysis was performed to
confirm the specificity of the PCR amplification. PCR efficiency was demonstrated by the
standard curve slope. Target gene mRNA was quantified by the delta-delta CT (2-DDCt)
method and normalized to the 18S subunit of rRNA (Applied Biosystems, Foster City, CA).
Total NO Product Measurement
Nitrite/nitrate levels (NO2− and NO−) were measured using a commercial assay
(Fluorometric NO Assay, EMD Biosciences, CA). Whole frozen fetal brains from NMX,
HPX and L-NIL+HPX animals were homogenized, centrifuged at 16,000 × g for 20min, and
the supernatant filtered through a 10KD cutoff filter at 14,000 × g for 1h. Enzyme cofactors
and nitrate reductase were added to each sample based on the manufacturer’s instructions.
The fluorescing reagent, DAN (2,3-diaminonaphthotriazole) was then added to the samples
and loaded onto 96 well plates which were read with a Biotek Synergy HT Multi-Detection
microtiter plate reader at the following settings: excitation wavelength: 360-365 nm;
emission wave-length: 430-450nm.
Statistical Analyses
All results are presented as the mean ± SEM. Comparisons between the control and study
groups were calculated by t-test or ANOVA as indicated. A value of P<0.05 was considered
to indicate statistically significant differences between or among groups.
RESULTS
Chronic Fetal Hypoxia Results in Selective Brain Injury
Chronic fetal hypoxia over the last 30% of gestation produced selective rather than global
brain injury as reflected by specific locations of increased ATF3, the development of gliosis,
apoptosis and decreased neuronal density (Figure 1-3, table 2). The major structures affected
were the cerebral cortex, hippocampus, and thalamic nuclei including hypothalamic nuclei
(Figure 1, 2 and Table 2). The impact of chronic hypoxia was widespread in the cerebral
cortex without area concentration. In contrast, significant injury in the hippocampus was
seen only in the cingulum, orices layer, CA1, CA2, and CA3; the impact on CA3 was
notable (Figure 2, Table 2).
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In the thalamic nuclei, chronic hypoxia increased the studied markers of injury in the
laterodorsal thalamic nuclei, post thalamic nuclei, ventral thalamic nuclei, paraventricular
thalamic nuclei, mediodorsal thalamic nuclei, central thalamic nuclei, and reuniens thalamic
nuclei. The degree of injury as reflected in the intensity of marker staining was greatest in
the reuniens thalamic nuclei, central thalamic nuclei, ventral thalamic nuclei, and
laterodorsal thalamus nuclei. In hypothalamic nuclei, injury was greatest in the dorsomedial
hypothalamic nuclei, ventromedial hypothalamic nuclei and lateral hypothalamus (Figure 2,
Table 2).
We also studied the expression of the injury markers at their mRNA levels. ATF3, GFAP
and Bax mRNA expressions were quantified by Q-rtPCR, and each gene was significantly
increased by chronic hypoxia in both whole brain samples and individually in LCM-derived
biopsy samples from cerebral cortex, hippocampus and thalamus nuclei (Figure 4). Thus,
chronic hypoxia mediated fetal brain damage increases the studied injury markers at both the
mRNA and protein levels in an anatomically selective manner.
Chronic Hypoxia Affects NOS Isoforms Differently
Chronic hypoxia increased total nitric oxide (NO) in whole fetal brain (Figure 10), with both
nNOS and iNOS expressions increased, but eNOS decreased (Figure 5 A). However, the
impact of chronic hypoxia on the expression of the three NO synthases varied by the isoform
and the structure injured. In hippocampus, iNOS expression was increased, eNOS decreased,
and nNOS unchanged (Figure 5 B). In cerebral cortex, only iNOS expression was increased;
there were no significant affect of chronic hypoxia on either nNOS or eNOS (Figure 5 C).
Lastly, in the thalamus including hypothalamic nuclei, nNOS and iNOS expressions were
both increased by chronic hypoxia while eNOS was unchanged (Figure 5 D).
Co-localization of iNOS, nNOS with the studied injury markers was sought using double
fluorescent staining techniques by region and cell type. iNOS and/or nNOS co-localized to
ATF3 and/or GFAP positive cells in cerebral cortex, hippocampus and thalamus nuclei
regions. Figure 6 illustrates the thalamic nuclei region where hypoxia increased iNOS in
thalamic nuclei (A1 vs. B1 and C1 vs. D1), neurons stained by ATF3 (A2 vs. B2) and glial
cells stained by GFAP (C2 vs. D2). The expression of iNOS co-localizes with both ATF3
and GFAP positive cells (B3 and D3).
Figure 7 demonstrates that hypoxia increases nNOS (A1 vs. B1 and C1 vs. D1), ATF3 (A2
vs. B2), GFAP (C2 vs. D2), and that nNOS co-localizes with both ATF3 and GFAP positive
cells (B3 and D3).
ATF3 is Present in Both Fetal Neuron and Glial Cells after Chronic Hypoxia
Neurons and glial cells were labeled by Tubulin III (red) and GFAP (green), respectively.
Chronic hypoxia significantly decreased neuronal density (Figure 8: A1 vs. B1), but induced
the development of gliosis (Figure 8: C1 vs. D1). ATF3 was significantly up-regulated by
chronic hypoxia in neurons identified by Tubulin III (yellow color in Figure 5: A3 and B3)
as expected. However, ATF3 also co-localized with the activated fetal glial cells as stained
by GFAP (Figure 8: C3 vs. D3).
L-NIL Attenuates Fetal Brain Injury from Chronic Hypoxia
The selective inhibition of iNOS using L-NIL was confirmed as L-NIL did not affect nNOS
and eNOS activation during chronic hypoxia (Figure 9, n=6), but it did significantly reduce
iNOS suggesting a feedback loop on transcription. Total NO was blunt by L-NIL (Figure 10,
n=6) illustrating thew major contribution of iNOS to the excess NO generated in the brain of
chronically hypoxic fetuses. As might be expected based on the afore findings, L-NIL
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significantly blunted the impact of chronic hypoxia on the studied brain injury genes (ATF3,
GFAP and Bax) (Figure 11). Lastly, and most importantly, L-NIL prevented the loss of
neurons due to chronic hypoxia as illustrated in the hippocampus.
COMMENT
The present investigation demonstrates that chronic fetal hypoxia over the last 30% of
pregnancy generates, in addition to IUGR, a pattern of fetal brain injury consistent with that
observed in human perinates. The sites of injury, cerebral cortex, hippocampus, and
thalamic and hypothalamic nuclei are selective rather than global and involve both gray and
white matter. Injury is associated with alterations in each of the NO synthases with the
induction of iNOS being ubiquitous which is also consistent with the limited human study
19.
Fetal hypoxia has duration, gestational age and selective anatomic and cellular effects.
Observations of the human fetal brain suggest acute ischemia-reperfusion at term pregnancy
preferentially affects the neuron, while in the preterm brain it is the white matter that is
preferential injured including gliosis 34. However, the impact of hypoxia is never
exclusively on the white or gray matter. The pre and immature oligodendrocytes that
characterize the preterm, periventricular white matter of the human fetus seem particularly
susceptible to hypoxia-ischemic injury, and that injury is associated with limited capacity to
resist oxidative stress35. We have previously shown that the human preterm fetus has limited
free radical scavenging capacity36, suggesting the potential for enhanced free radical toxicity
exists both prior to and shortly after preterm birth.
The clinical presentation of the resulting brain injury also differs between acute and chronic
hypoxia. Signs of encephalopathy after an episode of acute ischemia-reperfusion typically
begin during the early neonatal period. In contrast, early symptoms are relatively uncommon
after chronic hypoxial injury. Mixed phenotypes also occur.
Animal models of acute fetal ischemic hypoxia in early in gestation produce neuronal death
including Purkinje cells in the cerebellum, pyramidal cells in the hippocampus and cortical
neurons37. There is no resulting IUGR. The same insult can also generate diffuse white
matter injury including gliosis and cystic lesions in the periventricular region as often seen
in children with CP. An acute ischemic insult late in the pregnancy of sheep preferentially
affects fetal gray matter of the cerebral cortex and striatum 38.
In contrast to acute hypoxia, animal models of chronic hypoxia are associated with IUGR.
The growth of neural processes and synaptogenesis are affected globally39, 40. Neuronal loss
and ventriculomegaly are also associated with chronic hypoxia 41. Chronic hypoxia in fetal
sheep significantly delays the migration of cells from the germinal to the pyramidal layers of
the CA1 region in the ventral hippocampus decreasing pyramidal neuron density by 35%
decrease. It also reduces the area of Purkinje cell dendrite arborization in the cerebellum by
20%, and significantly decreases white matter area39.
Reactive oxygen and nitrogen species play important roles in the initiation of apoptotic
mechanisms and in mitochondrial permeability transition. The immature brain is particularly
susceptible to free radical injury since many of the scavenging systems are as yet
undeveloped and because the availability of iron for the catalytic formation of free radicals
is high. Oxidative stress is an early feature of acute cerebral ischemia and experimental
studies targeting the formation of free radicals reveal various degrees of protection after
perinatal insult by their inhibition. For example, we have previously demonstrated that
treating the dam with N acetyl cysteine prevents the development of a fetal inflammatory
response after the administration of lipopolysaccharide 42. Oxidative stress-regulated release
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of pro-apoptotic factors from mitochondria appears to play an important role in the
immature brain. And while neurons are considered more vulnerable to free radical damage
than glial cells, oligodendrocyte progenitors and immature oligodendrocytes in very
premature infants are selectively vulnerable to antioxidants depletion and free radical attack
43.
We have previously shown that this model of chronic fetal hypoxia generates inflammatory
response in fetal multiple organs including the brain13, 44. This response is unique to the
fetus as the brain of the dam is unaffected. In the present study, we map for the first time the
geography of fetal brain injury resulting from chronic fetal hypoxia and reveal specific
injury to neuronal and glial cells at locations analogous to those reported in children with
CP. This map provides a reference point for the future study of chronic hypoxia induced
fetal brain injury and the impact of therapeutic interventions to ameliorate or prevent the
injury. Further, we link for the first time the injury from chronic hypoxia to specific changes
in NOS isoenzymes.
iNOS was expressed by both neuronal and glial cells in all injured areas. Using the iNOS
selective inhibitor, L-NIL, we demonstrated that most of the hypoxia induced increase in
total NO was a reflection of excess iNOS activity, and that inhibiting iNOS blunted or
eliminated the expected increases in the injury indices (ATF3, GFAP and Bax). Increased
iNOS results in excess oxygen free radical production which the immature cells of the
perinatal brain are poorly equipped to scavenge 45. As a result of iNOS inhibition, the loss of
neurons prevented despite continued fetal hypoxia. This finding raises the potential of
antenatal therapy. Unfortunately, iNOS of unknown role is ubiquitously expressed in the
human placental bed and periodically in various fetal organs. However, pharmacologic
blockade elsewhere along the pathophysiological pathway may prove practical.
We also found that chronic hypoxia decreased eNOS in the hippocampus and increased
nNOS in the thalamus (again, in both neuronal and glial cells). This pattern of adaptation
would indeed exacerbate the impact of any additional, acute ischemic-reperfusion event (e.g.
umbilical cord compression) that might occur during the pregnancy or labor converting a
chronic injury with a subclinical phenotype into one with a clinically detectable phenotype.
These common events would not otherwise produce clinically significant injury to a healthy
fetus, but in the chronically hypoxic fetus with NOS adaptations, they constitute a ‘second
hit’ to the brain and explain in part the association between CP ‘due’ to an acute intrapartum
event with co-existing IUGR. It might also explain the synergistic relationship between
IUGR and infection/inflammation noted epidemiologically as the diagnosis of infection is
usually based on evidence of histological evidence of inflammation rather than the
identification of bacteria. Even with the application of PCR, bacteria are detectable in no
more than half of all cases46. The NOS maladapted perinatal brain, especially if preterm
would then suffer a ‘third hit’ when challenged by the obligatory increase in oxygen free
radicals generated immediately after birth when arterial oxygen suddenly increases before
the induction of adequate scavenging capacity. The ‘second’ and ‘third hits’ to the perinate
could explain how a short infusion of magnesium sulfate could reduce the risk of CP by
about 40% 47,48 should the magnesium interfere with or ameliorate the inflammatory
response or enhance the neonatal ability to quench free radicals. The efficacy of magnesium
sulfate suggests that the ‘second hit’ and ‘third hit’ to the perinatal brain peripartal is
responsible for the disease phenotype in some 40% of CP cases. In the remaining 60%, the
degree of antenatal injury is already sufficient that a disease phenotype is unavoidable even
with optimal perinatal management.
We have previously demonstrated that the fetal response to chronic hypoxia differs from the
maternal response. For example, NOS protein expression is differently altered by hypoxia in
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fetal and adult heart 49. The current investigation reveals another difference in the response
to hypoxia between fetus and adult. While AT3F in adults is considered a selective marker
for neuronal injury, we find that both the neuronal and glial cell produce ATF3 when injured
by hypoxia beginning at 0.7 gestation. ATF3 is a member of the mammalian activation
transcription factor/cAMP responsive element-binding (CREB) protein family of
transcription factors. Multiple transcript variants encoding two different isoforms are
reported50 . The longer isoform represses rather than activates transcription from promoters
with ATF binding elements. The shorter isoform (deltaZip2) lacks the leucine zipper
protein-dimerization motif and does not bind DNA. It stimulates transcription presumably
by sequestering inhibitory co-factors away from the promoter. ATF3 interacts with C-jun,
DNA damage-inducible transcript 3 and P53 50, 51. In prior study, we demonstrated chronic
fetal hypoxia increases P-53 expression in the hippocampus in proportion to the level of
hypoxia 44. We cannot exclude the possibility of a unique fetal splice variant that would
explain the differences in expression between adult and fetal glial cells.
Clearly, the regions injured in association with chronic hypoxia could account for much of
the spectrum of abnormalities associated with perinatal brain injury. For example, the roles
of the cerebral cortex include the initiation of movement. The hippocampus is important for
learning and memory. The thalamus, which is located between the cerebral cortex and
midbrain both in terms of location and neurological connections, is important for relaying
sensation, special sense and motor signals to the cerebral cortex, along with the regulation of
consciousness, sleep and alertness. Virtually every sensory system except smell has a
corresponding thalamic nucleus that receives sensory signals that links to an associated
primary cortical area. Loss of thalamic neurons could have significant impact on refined
function; profound thalamic damage can produce coma. A core function of the
hypothalamus is to link the nervous and endocrine systems through the pituitary; it
synthesizes and secretes neurohormones that in turn stimulate or inhibit the secretion of
pituitary hormones. The hypothalamus also controls body temperature, hunger, thirst,
fatigue, and circadian cycles.
In conclusion, chronic fetal hypoxia over the last 30% of the guinea pig gestation produces
an anatomically selective and cell specific pattern of brain injury characterized by neuronal
loss and a reactive gliosis. All injured sites display the induction of iNOS and in some
locales, nNOS is increased and or eNOS decreased. The impact of chronic hypoxia on the
NO synthases is an example of an adaptive response that in terms of the birth process is
maladaptive, increasing the susceptibility of the perinatal brain to what would normally be
limited but well tolerated episodes of acute ischemia reperfusion.
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Figure 1. Chronic Fetal Hypoxia Results in Selective Anatomic Brain Injury
Sample photomicrographs from mirror image coronal sections at the interaural level of
6.72mm to 5.40 mm (Bregma: from −2.28 mm to −3.60mm) including cerebral cortex,
hippocampus, and thalamic nuclei from hypoxic (n=6) and control fetuses (n=6) stained for
ATF3 (10x), GFAB (10x), TUNEL (10x), and Nissl (20x). Chronic hypoxia (10.5% O2 over
the last 30% of gestation) visually increases ATF3, GFAB and TUNEL staining with an
accompanying decrease in neuronal density.
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Figure 2. MAP of the Fetal Brain Injury Associated with Chronic Hypoxia
Injured areas in the mirror sections were selected at the interaural level of 6.72mm to 5.40
mm (Bregma: from −2.28 mm to −3.60mm) were reconstructed based on quantification of
immunostaining and TUNEL staining. The quantification of ATF3, GFAP and TUNEL were
projected onto the standard coronal section. Chronic fetal hypoxia increased ATF3 (red),
GFAP (green), and TUNEL (blue) staining specifically in cerebral cortex, hippocampus, and
thalamic / hypothalamic nuclei. In cortex, the damage was widely distributed, while in
hippocampus, the injury was greatest in cingulum, orices layer, and CA1, CA2, CA3 layers.
In thalamic nuclei, the injury was greatest in the reuniens, central, ventral, and laterodorsal
thalamic nuclei. The injury markers were also up regulated in the dorsomedial and
ventromedial hypothalamic nuclei and lateral hypothalamus.
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Figure 3. Neuronal Loss is Associated with Chronic Fetal Hypoxia
Neural cell density expressed as the total Nissl staining cells/ mm2. Five areas were
randomly selected from each slide, digitally photographed, and neuronal density quantified
using the Stereo Investigator 8.0 system. Chronic hypoxia over the latter 30% of gestation
reduced neuronal density by some 20% in fetal cerebral cortex, hippocampus and thalamus
nuclei.
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Figure 4. mRNA Expression of Brain Injury Indices is Increased by Chronic Fetal Hypoxia
Cerebral cortex, hippocampus and thalamus nuclei were selectively biopsied at the sites of
injury discovered in the brain slices using laser capture microdissection (LCM) and ATF3,
GFAP and Bax mRNA expressions measured by Q-rtPCR. The mRNA expression for each
injury marker was up regulated by chronic hypoxia (n=6, p<0.05) in both whole brain
samples and at each of the LCM biopsied sites. These results, combined with the
immunostaining findings demonstrate that chronic hypoxia selectively injures the fetal brain
and that both mRNA and protein levels are increased.
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Figure 5. Chronic Hypoxia Differentially Impacts NO Synthases in a Manner that Reflects the
Anatomic Location
NOS isoform mRNA was measure by Q-rtPCR in whole brain and at sites of injury in
cerebral cortex, hippocampus and thalamus biopsied using LCM. In fetal whole brain (panel
A), both nNOS and iNOS expressions were increased, but eNOS decreased. However, the
impact of chronic hypoxia on NOS isoform expression varied by site. iNOS was increased,
eNOS was decreased, and nNOS unchanged in hippocampus (panel B). In cerebral cortex,
only iNOS was increased (panel C). In thalamus, nNOS and iNOS were both increased by
chronic hypoxia but eNOS was unchanged (panel D).
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Figure 6. iNOS Co-localizes with Markers of Brain Injury
Co-localization of iNOS and injury markers was sought using double fluorescent staining
techniques (cross section hippocampus, ATF3 and GFAP, 10x). Chronic hypoxia increased
iNOS (panels A1 vs. B1 and C1 vs. D1), ATF3 (panels A2 vs. B2) and GFAP panels (C2 vs.
D2). iNOS co-localized with both ATF3 and GFAP positive cells (panels B3 and D3).
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Figure 7. nNOS Co-localizes with Markers of Brain Injury
Co-localization of nNOS and injury markers was sought using double fluorescent staining
techniques (cross section hippocampus, ATF3 and GFAP, 10x). Chronic hypoxia increased
nNOS (panels A1 vs. B1 and C1 vs. D1), ATF3 (panels A2 vs. B2), GFAP (panels C2 vs.
D2). nNOS co-localized with both ATF3 and GFAP positive cells (panels B3 and D3).
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Figure 8. ATF3 is Present in Injured Fetal Neuronal and Glial Cells During Chronic Hypoxia
Neuronal and glial cells were selectively stained for Tubulin III and GFAP, respectively
(cross section hippocampus, 10x). Chronic fetal hypoxia increased ATF3 (panels A2 vs. B2,
C2 vs. D2). Chronic hypoxia decreased neuronal density (panels A1 vs. B1). GFAP was
activated by chronic hypoxia indicating the development of gliosis (panels C1 vs. D1).
However, and in contrast to adult studies, ATF3 was not unique to neurons (A3 vs. B3), but
also co-localized to glial cell after chronic hypoxia (panels C3 vs. D3).
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Figure 9. L-NIL Selectively Inhibits iNOS in Fetal Brain During Chronic Hypoxia
NOS isoforms mRNA expression was quantified by Real-time PCR using the fetal whole
brain tissue (n=6). nNOS and iNOS but eNOS was up-regulated significantly by chronic
hypoxia and unaffected by L-NIL; only iNOS was attenuated by L-NIL.
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Figure 10. L-NIL Blunts the Increase in Total NO in Fetal Brain Secondary to Chronic Hypoxia
Whole fetal brain total NO (NO2− and NO−) was increased by chronic fetal hypoxia (HPX,
n=6) vs. control animals (NMX, n=6), but significantly decreased in L-NIL treatment group
vs. HPX.
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Figure 11. L-NIL Reduces Indices of Brain Injury During Chronic Hypoxia
ATF3, GFAP, and Bax were applied as indices of brain injury (n=6). Chronic hypoxia up
regulated the expression of each; L-NIL attenuates the effect of unopposed chronic hypoxia.
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Figure 12. L-NIL Prevents Neuronal Loss in Fetal Hippocampus During Chronic Hypoxia
The impact of L-NIL on neuronal loss during chronic fetal hypoxia is illustrated here for
hippocampus. Neural cell density is expressed as the total Nissl staining cells/ mm2. L-NIL
essentially eliminated neuronal loss secondary to chronic hypoxia.
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Table 1
Antibodies Species and Dilution Factors Information




























(BD bioscience) Mouse 200








Donkey anti rabbit + FITC
(Jackson)
Anti-nNOS
(Cell signaling) Rabbit 100








Donkey anti mouse + Red-X
(Jackson)
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Table 2




Cerebral cortex Global wide ++ ++ ++
Hippocampal region
cingulum − +++++ −
orices layer hippocampus +++ +++ +++
CA1 + + +
CA2 + + +
CA3 ++++ ++++ ++++
Thalamic nuclei
laterodorsal thal nu ++ ++ ++
post thalamic nu + + +
ventrol thalamic nu ++ ++ ++
paraventricular thal nu + + +
mediodorsal thal nu + + +
central thalamic nu ++ ++ ++
reuniens thalamic nu +++ +++ +++
others − − −
Hypothalamic nuclei
dorsomed hypothal nu + + +
ventromed hypothal nu + + +
lat hypothal + + +
others + + +
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